WHO
SAFETY ALERT
10th Invitation to Manufacturers of Medicinal Products for Treatment of Neglected Tropical Diseases to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
Published: 10/29/2026Detected: 10/29/2026
Summary preview
Adds Acoziborole 320 mg tablets to the WHO Prequalification Unit’s updated invitation for manufacturers to submit an Expression of Interest (EOI) for product evaluation for human African trypanosomiasis (g-HAT).
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
rare_diseases
manufacturing
quality
clinical
safety
labeling
#WHO prequalification
#expression of interest
#EOI
#Neglected Tropical Diseases
Official Source Document Source Verified
Access the original document directly from WHO.
More from WHO
- Invitation to a Webinar on managing reportable changes10/29/2026
- New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices10/29/2026
- PQT/AMD newsletter - Q3 2026, Issue 54 is now available10/29/2026
- PQ Webinar: Launch of WHO Prequalification of Medical Devices10/29/2026
- VCP Updates - October 202610/29/2026